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Ellis Reinherz and I were riding in a luxury Boston Coach to
Long Island in New York State driven by a professional dri-
ver. This was not a vacation trip to one of the best leisure
places in the United States. We were heading toward the
National Laboratory at Brookhaven, where a powerful X-ray
source is available in a facility called a synchrotron. The aim
of our trip was to use a strong X-ray to shoot the crystals of
the Tcell receptor (TCR) we had just managed to grow after
considerable effort for three-dimensional structure determi-
nation. In 1996, this was one of the hottest projects in
structural biology as well as in immunology.
I got acquainted with Ellis when I was a visiting scholar
from China working in Stephen Harrison’s lab at Harvard for
another high-proﬁled project: to solve the structure of CD4.
CD4 had long been known as the co-receptor of TCR,
playing a key role in the immune system since its description
in 1979 (Reinherz et al., 1979). But in 1988 to determine the
structure of CD4 had a much more urgent goal behind. In the
early 1980s, HIV was discovered as the cause of the life-
threatening acquired immunodeﬁciency syndrome (AIDS),
and soon CD4 was identiﬁed as the primary receptor of HIV.
The virus uses CD4 to open the door for invading the Tcell,
eventually destroying the whole immune system, hence the
name of AIDS. Steve and the late Don Wiley initiated and
directed this extremely important structure project with a
clear goal in mind: To solve the structure of CD4, which
might be potentially the ﬁrst step to ultimately stop the HIV
pandemic. CD4 as a transmembrane receptor has four
immunoglobulin (Ig) like domains on the cell surface. Steve
was seeking all possible sources to collect the protein
sample with different domain constituents for crystallization.
Ellis was one of the sources. Ellis’s lab was able to express
protein composed of the N-terminal two domains of CD4. By
then it was already known that the very N-terminal domain of
CD4 is solely responsible for virus binding. We were hoping
that a two-domain construct would be sufﬁcient for this pur-
pose. My wife was assigned to grow crystals. She often was
handed over the protein sample by Ellis’s technician in
Harvard Square, a few miles away from his lab near the
downtown Boston! The protein Ellis produced did yield
excellent crystals. It was a truly exciting moment when for
the ﬁrst time, I watched the high-resolution diffraction pattern
of the CD4 crystal on the detector using the home source
X-ray machine. I knew the structure could be on the horizon.
At that time, there was no fancy software capable of com-
puting the phasing, electron density modiﬁcation and auto-
matic model building, poly-peptide tracing on the density
map from the experimental phasing was always a challenge.
After I obtained the multiple-isomorphous replacement map,
it was quite difﬁcult to interpret the noisy map. Using a
homologous immunoglobulin domain as a model, Steve
himself did the N-terminal domain ﬁtting on the graphics
machine to make the breakthrough. We then successfully
traced the second domain on a so-called mini-map, which
was a stacked plastic sheet with electron density maps
contoured in an old-fashion way to determine the proteins’
backbone structure. The international competition to deter-
mine this structure was unprecedented. My friend Jack
Strominger, a veteran immunologist at Harvard, was once
teasing me by saying that “Jia-huai, there are at least 15 labs
in the world working on the same project!” In the end, two
labs advanced far enough to reach the agreement of coor-
dinating the publication together (Ryu et al., 1990; Wang
et al., 1990). The other lab was led by Wayne Hendrickson at
Columbia University. The news on the two Nature articles
was in the New York Times in 1990. It is interesting to add
that it was not until ten years later in 2001 when I was
already on the faculty of Dana-Farber Cancer Institute and
Harvard Medical School that Ellis and I published another
structure of CD4 (Wang et al., 2001). This time it was in
complex with the class II MHC molecule, in which we
showed clearly how HIV uses a similar strategy to outcom-
pete CD4’s physiological binding partner MHC to grab CD4
for the invasion. That effort complemented the ﬁrst class II
MHC-restricted TCR in complex with pMHCII to be described
by us in 1999 (Reinherz et al., 1999). In those two structures,
the complexes included the same pMHCII, allowing us to
infer and create a molecular model of the TCR-pMHC-CD4
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riuzza a decade later (Yin et al., 2012).
On the 5-hour trip to Long Island, Ellis and I had to
carefully hold, by turn, the styrofoam box in which the crys-
tallization trays were carefully packed. The tiny crystals grew
in 2 microliter droplets in 24-well trays. We just could not risk
any damage to these extremely valuable but fragile crystals,
so we handheld the box all the way to avoid any signiﬁcant
shaking when the coach was bumping on the road. Pro-
ducing these soluble TCR molecules for crystallization was
not an easy job, and still isn’t almost twenty years later. In
Ellis’s lab, a team led by two highly skillful molecular biolo-
gists and protein chemists tried every available technique to
clone, express and purify several kinds of TCR. One of the
challenging issues to produce soluble TCR molecules is that
like many other cell surface receptors, TCR molecules are
glycosylated. Bacterium expression systems do not have
this post-translational modiﬁcation mechanism. Without gly-
cosylation, the bacteria-expressed protein may be less sol-
uble and tends to aggregate. At that time knowledge about
the role of glycans was very limited. We just had no idea
whether the glycan on the TCR molecule was of biological
signiﬁcance. One of the postdoctoral fellows in the lab turned
to the mammalian system, the CHO (Chinese Hamster
Ovary) cell to express the protein, because these cells can
produce glycoproteins. Then another headache struck.
Glycosylation is notoriously heterogeneous. In order to grow
crystals of diffraction quality, the prerequisite is to have a
chemically homogeneous protein sample. Fortunately, sci-
entists around that time developed an engineered CHO,
termed CHO lec
–, which is able to express homogeneous,
mannose-enriched glycoprotein in large quantities (Stanley,
1989). At that point we started to have some ugly-looking
crystals of TCR. One more advantage of using the CHO lec
–
system is that the produced glycoprotein can be treated with
some enzymes for deglycosylation. All of a sudden by using
the deglycosylated homogenous TCR sample, beautiful
crystals appeared. This marked a big step toward our ﬁnal
goal. Using the home source X-ray machine, around 8–10 Å
diffraction spots could be seen for these crystals. At that
moment I knew a synchrotron trip was inevitable.
Bob Sweet was in charge of the National Synchrotron
Light Source (NSLS) beamline X12C at Brookhaven. I
actually met Bob personally more than ten years ago when I
paid a visit to David Eisenberg’s lab at UCLA in 1980. Bob
was David’s postdoctoral fellow then who hosted my visit.
We had a very interesting talk on his project. With Bob as a
host at NSLS, I felt very comfortable. He was friendly and
introduced us to his facility, after Ellis and I safely arrived and
most of crystals seemed to survive. On the site also was a
group from Albert Einstein College led by Jim Sacchettini,
another X-ray crystallographer with whom Ellis had previ-
ously established a collaboration. That was the very early
days when protein crystallographers just began to freeze
protein crystals to collect diffraction data at around −140°C.
To protein crystallographers, the synchrotron radiation
source was like a double-edged sword. On one hand, the
synchrotron X-ray source was so powerful, it had made
possible the data collection of those weakly diffracting
crystals like TCR. On the other hand, the X-ray was so
strong that it quickly damaged these fragile crystals before
any complete data set could be ﬁnished. To collect a data set
at −140°C under cold stream generated from liquid nitrogen
was invented early in 1990’s to circumvent the problem.
X-ray damage was no longer a headache. Bob had a well
set-up facility for all these purposes.
I would never have expected to almost lose all my crystals
brought to Brookhaven that day. I thought I was well pre-
pared for the data collection because I had already carried
out all the experimental procedures at home in Boston. The
well-developed crystals were safely harvested from the tiny
droplet into a large well with so-called cryo-protectant solu-
tion. These incubated crystals could then be ﬁshed up using
a small nylon loop supported on a metal cap, and quickly
ﬂash frozen by mounting the cap on the diffractometer
equipped with cold stream from liquid nitrogen, ready to
shoot with X-rays. The problem arose when the cap was
mounted on the machine by the magnetic force. On Bob’s
machine, the magnet was so strong that the moment a
crystal was put on, the force that attracted the cap on the
machine shook the crystal off from the nylon loop, no matter
how careful I was. We only had three crystals had left. The
atmosphere, not the crystals, seemed frozen. Ellis sug-
gested that everyone leave the room. He then turned to me
and said: “Jia-huai, I am going to buy lunch for you. Just
relaxed”. That did help reduce the tension! I used my right
hand to ﬁsh crystal, at the same time I used my left hand to
help hold the cap more smoothly and set the crystal on. A
beautiful diffraction pattern showed up. This was our ﬁrst
2.8 Å data set of TCR crystal! That would lead to our 1998
published study (Wang et al., 1998).
Like CD4, the TCR structure project was also in a very
tense competition. Christopher Garcia in Ian Wilson’s group
at Scripps Institute and David Garboczi in Don Wiley’s group
at Harvard were far ahead of us in solving the ﬁrst MHC
class I restricted TCR. By the time we were trying to deter-
mine the structure by locating the heavy atom (in fact it was
selenium that was genetically replacing the sulfur atom in
metheonine) sites, these two groups had published their
structures of TCR alone and in complex with pMHC (Gar-
boczi et al., 1996; Garcia et al., 1996). We then could use
Wilson’s structure to quickly solve ours using molecular
replacement and published in EMBO J in 1998 (Wang et al.,
1998). We also took advantage of being the third group to
compare the three TCR/pMHC structures and identiﬁed a
common binding mode of TCR onto pMHC (Teng et al.,
1998). With over several dozen TCR complex structures
currently deposited in the Protein Data Bank, this common
docking scheme still holds.
The ecto-domains of α and β subunits of TCR are both
made up of two Ig-like domains: a variable domain and a
constant domain. There are two obvious deviations of the
RECOLLECTION Jia-huai Wang
650 © The Author(s) 2014. This article is published with open access at Springerlink.com and journal.hep.com.cn
P
r
o
t
e
i
n
&
C
e
l
ltwo TCR constant domains from a canonical Ig-like domain.
First is the strange constant domain of α subunit. It could
hardly be designated as an Ig-like domain, which normally
consists of two β sheets packing face-to-face. The TCR α
constant domain does have an inward β sheet facing the
constant domain of β subunit. But the outward face is no
longer a β sheet. One of the strands curves into a helical
conformation, whereas the other two strands just loosely
hang around. When our structure got published, Ian Wilson
told me that he felt so much relieved to see that our α con-
stant domain was just like theirs since the Wiley group could
not trace this outside sheet in their structure. We still have no
idea even today why this domain appears so poorly struc-
tured. This became even more of a mystery when Jamie
Rossjohn published his pre-TCR structure (Pang et al.,
2010), a TCR precursor that only exists during T cell devel-
opment in the thymus. The pre-TCR molecule does not have
the variable domain of its α subunit. However its constant
domain assumes a perfect canonical Ig-like domain!
As a structural biologist, I was also fascinated by the
second deviation of TCR structure from the normal Ig-like
domain, the unusually long loop between the F strand and G
strand, stretching out of the constant domain of the β sub-
unit. I noticed that this was a common feature shared in the
other two published structures. We now know that this is a
very conserved structural feature of αβ TCR molecules and
evolved with the molecular speciation of CD3γ and CD3δ
from a common precursor molecule several hundred million
years ago (Kim et al., 2010). Remarkably, in the center of the
FG-loop lies a bulky tryptophan amino acid residue, around
which exquisite hydrogen bonds and hydrophobic interac-
tions make the loop a relatively rigid entity (Wang et al.,
1998). My structural observation immediately caught Ellis’s
attention. He thought this loop might bear an important
function in the TCR signaling process by rigidifying this
subunit and in turn pressing on the heterodimeric CD3 sig-
naling molecules that collectively comprise the TCR com-
plex. Sixteen years have passed since this early structural
observation and we have never stopped investigating the
role that this unique FG-loop might play in TCR signaling.
The issue has frequently been the discussing topics in our
weekly lunch meeting. Our most recent collaborative efforts
are to use single molecule technique to explore the function
of this key structural element.
“This is my fourteen-year dream”, said Ellis to me on the
way back from that Brookhaven trip. He was referring to the
day he and his colleagues at Dana-Farber Cancer Institute
discovered the human TCR in the early 1980s. We both
were so excited and kept chatting about how to proceed that
we didn’t notice the downpour going on outside the coach.
We ﬁnally realized that the poor driver missed our exit to
Boston on the highway and we were on the way to Maine!
The trip took more than two hours longer it should be, yet the
sweet memory is still kept vividly present in my brain ever
since.
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